If you're looking to boost your portfolio with some quality shares, then you might want to look at the ones listed below.
Here's why these quality ASX 50 shares have been tipped as ones to buy right now:
Image source: Getty Images
NEXTDC Ltd (ASX: NXT)
The first ASX 50 share to look at is NEXTDC. It is Australia's leading data centre operator with a collection of nine world-class centres located across the country. This doesn't include the M3 and S3 centres under development and the S4 centre which has just been announced.
Nor does it include its potential expansion into the Asian market after opening offices up in Singapore and Tokyo. Given the size of these markets, this could provide NEXTDC with very long growth runways in the future.
For now, though, NEXTDC continues to generate strong revenue and operating earnings growth in Australia. For example, during the first half of FY 2021, the company posted a 27% increase in data centre services revenue to a record $121.6 million and a 29% increase in EBITDA to $65.7 million. This was underpinned by a 33% lift in contracted utilisation to 71MW, a 16% lift in customers, and a 16% rise in interconnections.
More of the same is expected in the second half and in FY 2022 according to analysts at Goldman Sachs. It is for this reason that the broker has a conviction buy rating and $14.80 price target on its shares.
Ramsay Health Care Limited (ASX: RHC)
Another ASX 50 share to look at is Ramsay Health Care. It provides quality healthcare services to over 8 million patients each year through a network of facilities across 10 countries and over 500 locations.
Although trading conditions have been tough over the last 18 months and recent lockdowns are likely to weigh on its immediate term performance, the company has been tipped to bounce back strongly. Particularly given the pent-up demand for healthcare services.
It is for this reason that analysts at Macquarie remain positive on the company. Last week they retained their outperform rating and cut their price target on its shares slightly to $73.35. It has trimmed its near term forecasts due to lockdowns but remains positive on its medium term growth.
